Wide Ranks

HLN

Haleon plc

9.72

Top Statistics
Market Cap 43 B Forward PE 26.02 Revenue Growth -0.60 %
Current Ratio 0.00 Trailing PE 29.45 Earnings Growth 34.80 %
Profit Margins 10.75 % Peg Ratio Dividend Yield 1.62 %
Enterprice / EBITA 36.27 Enterprise / Revenue 8.66 Price To Sales Trailing12 Months 3.91
Profitability
Profit Margins 10.75 % Operating Margins 25.36 %
Balance Sheet
Total Cash 531 M Total Cash Per Share 0.0580 Total Debt 9 B
Total Debt To Equity 54.17 Current Ratio 0.00 Book Value Per Share 1.82
All Measures
Short Ratio 195.00 % Message Board Id finmb_1671690919 Shares Short Prior Month 10 M
City Weybridge Uuid 670a898e-8728-31c7-aec8-d56d816466bf Previous Close 9.59
First Trade Date Epoch Utc 1 B Book Value 1.82 Beta 0.2400
Total Debt 9 B Volume 5 M Price To Book 5.35
Fifty Two Week Low 7.89 Total Cash Per Share 0.0580 Total Revenue 11 B
Shares Short Previous Month Date 1 B Target Median Price 10.88 Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins 25.36 % Last Dividend Value 0.0510
Target Mean Price 10.76 Net Income To Common 1 B Ask 10.00
Implied Shares Outstanding 4 B Trailing Peg Ratio 175.07 % Last Fiscal Year End 1 B
Average Daily Volume10 Day 6 M Average Volume10days 6 M Total Cash 531 M
Next Fiscal Year End 1 B Revenue Per Share 2.45 Held Percent Insiders 0.0437
Ebitda Margins 23.89 % Dividend Rate 0.1600 Trailing PE 29.45
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 9.59
Target Low Price 9.50 Gmt Off Set Milliseconds -18000000 Fifty Day Average 9.95
Open 9.69 Dividend Yield 1.62 % Time Zone Short Name EST
Trailing Eps 0.3300 Day Low 9.68 Address1 The Heights
Trailing Annual Dividend Rate 0.0620 Price Hint 2 Shares Outstanding 4 B
Target High Price 11.77 Website https://www.haleon.com 52 Week Change 0.1355
Average Volume 5 M Earnings Quarterly Growth 32.90 % Forward Eps 0.4200
Recommendation Key none Compensation As Of Epoch Date 1 B Is_sp_500 False
Regular Market Day High 9.78 Profit Margins 10.75 % Debt To Equity 54.17
Fifty Two Week High 10.80 Day High 9.78 Shares Short 7 M
Regular Market Open 9.69 Industry Key drug-manufacturers-specialty-generic Bid 9.00
Earnings Growth 34.80 % Enterprise To Revenue 8.66 Revenue Growth -0.60 %
Shares Percent Shares Out 0.0026 Currency USD Time Zone Full Name America/New_York
Market Cap 43 B Is_nasdaq_100 False Zip KT13 0NY
Payout Ratio 46.74 % Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic
Ex Dividend Date 1 B Regular Market Day Low 9.68 Held Percent Institutions 0.1151
Long Name Haleon plc Current Price 9.72 Address2 Building 5, First Floor
Enterprise To Ebitda 36.27 Trailing Annual Dividend Yield 0.65 % Financial Currency GBP
Current Ratio 0.00 Gross Margins 62.20 % Industry Disp Drug Manufacturers - Specialty & Generic
Number Of Analyst Opinions 4 Country United Kingdom Float Shares 7 B
Two Hundred Day Average 9.09 Enterprise Value 97 B Price To Sales Trailing12 Months 3.91
Forward PE 26.02 Regular Market Volume 5 M Last Dividend Date 1 B
Ebitda 2 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022.

Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.